Provided by Tiger Trade Technology Pte. Ltd.

Organon & Co

6.41
-0.0750-1.16%
Volume:1.03M
Turnover:6.65M
Market Cap:1.67B
PE:8.90
High:6.51
Open:6.44
Low:6.38
Close:6.48
52wk High:15.88
52wk Low:6.18
Shares:259.98M
Float Shares:258.73M
Volume Ratio:0.49
T/O Rate:0.40%
Dividend:0.08
Dividend Rate:1.25%
EPS(TTM):0.7200
EPS(LYR):0.7200
ROE:30.56%
ROA:6.22%
PB:2.21
PE(LYR):8.90

Loading ...

FDA Approves Organon and Henlius' POHERDY as First Perjeta Biosimilar in US

Reuters
·
Nov 17, 2025

Henlius and Organon Announce US FDA Approval of Poherdy® (Pertuzumab-Dpzb), the First Perjeta (Pertuzumab) Biosimilar in the US

THOMSON REUTERS
·
Nov 17, 2025

Executive Chair Carrie Smith Cox Acquires Common Shares of Organon & Co

Reuters
·
Nov 14, 2025

Organon & Co. Files Initial Beneficial Ownership Statement for Juliana Papa Drinane, Interim Head of Manufacturing & Supply

Reuters
·
Nov 13, 2025

Organon Analysts Cut Their Forecasts Following Q3 Results

Benzinga
·
Nov 12, 2025

Stock Track | Organon & Co Plummets 5.06% as Morgan Stanley and JP Morgan Cut Target Prices

Stock Track
·
Nov 11, 2025

Organon price target lowered to $9 from $10 at Morgan Stanley

TIPRANKS
·
Nov 11, 2025

Organon & Co. Reports Modest Q3 Revenue Growth

TIPRANKS
·
Nov 11, 2025

Organon Cuts 2025 Sales Outlook Despite Earnings Beat

Benzinga
·
Nov 10, 2025

Organon Shares up 7.2% After Q3 Results Beat

THOMSON REUTERS
·
Nov 10, 2025

Stock Track | Organon Soars 5.16% in Pre-Market as Q3 Earnings Beat Estimates, Despite Lowered Revenue Guidance

Stock Track
·
Nov 10, 2025

Stock Track | Organon Soars 5.16% as Q3 Earnings Beat Estimates, Despite Lowered Revenue Guidance

Stock Track
·
Nov 10, 2025

GUIDANCE: (OGN) Organon Expects Full Year 2025 Revenue Range $6.20B to $6.25B, vs. FactSet Est of $6.29B

MT Newswires Live
·
Nov 10, 2025

Healthcare products maker Organon beats Q3 profit estimates, cuts FY forecast

Reuters
·
Nov 10, 2025

Organon Shares up 1.2% Premarket After Q3 Results Beat

THOMSON REUTERS
·
Nov 10, 2025

Organon Reports VTAMA Cream Achieves Early Skin Clearance in Children With Atopic Dermatitis

Reuters
·
Nov 10, 2025

Organon Reports Q3 2025 Revenue of $6.2 Billion to $6.25 Billion

Reuters
·
Nov 10, 2025

Organon Q3 Adj. EPS $1.01 Beats $0.94 Estimate, Sales $1.602B Beat $1.575B Estimate

Benzinga
·
Nov 10, 2025

BRIEF-Organon Q3 Adjusted EPS USD 1.01 Vs. IBES Estimate USD 0.94

Reuters
·
Nov 10, 2025

Organon Outlook FY Revenue USD 6,200-6,250 Million

THOMSON REUTERS
·
Nov 10, 2025